[O1] Oral Session 1　消化器1（上部消化管）
【E】

[O1-5] Bemarituzumab as a 1L Therapy for Advanced GC/GEJ - A Subgroup Analysis of East Asian Patients from the FIGHT trial

^○山口 研成¹, Akira Ooki¹, Yoon-Koo Kang², Keun-Wook Lee³, Li-Yuan Bai⁴, Helen Collins⁵, Yingsi Yang⁵, Khalid Mezzi⁵, Daniel Catenacci⁶, Peter Enzinger⁷, Zev Wainberg⁸ (1.公益財団法人がん研究会 有明病院 消化器化学療法科, 2.University of Seoul, South Korea, 3.Seoul National University Bundang Hospital,South Korea, 4.China Medical University, Taiwan, 5.Amgen Inc, United States, 6.University of Chicago, United States, 7.Dana Farber Cancer Institute, United States, 8.University of California, Los Angeles, United States)